Cargando…

Ultrathin-strut biodegradable polymer versus durable polymer drug-eluting stents: a meta-analysis

OBJECTIVES: Determine whether an ultrathin biodegradable polymer sirolimus-eluting stent (‘Orsiro’—BP-SES) has clinical benefits over second-generation durable polymer drug-eluting stents (DP-DES). METHODS: We conducted a prospective systematic review and meta-analysis of randomised clinical trials...

Descripción completa

Detalles Bibliográficos
Autores principales:	Monjur, Mohammad Riashad, Said, Christian F, Bamford, Paul, Parkinson, Michael, Szirt, Richard, Ford, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Interventional Cardiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552849/ https://www.ncbi.nlm.nih.gov/pubmed/33046595 http://dx.doi.org/10.1136/openhrt-2020-001394

Ejemplares similares

Biodegradable polymer-coated thin strut sirolimus-eluting stent versus durable polymer-coated everolimus-eluting stent in the diabetic population
por: Gasior, Pawel, et al.
Publicado: (2021)

Ultrathin Strut Biodegradable Polymer-Coated Sirolimus-Eluting Coronary Stents: Patient-Level Pooled Analysis From Two Indian Registries
por: Babu Pothineni, Ramesh, et al.
Publicado: (2023)

Safety and efficacy of ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer drug-eluting stents: a meta-analysis of randomized trials
por: Zhu, Ping, et al.
Publicado: (2018)

Ultrathin Strut Biodegradable Polymer Sirolimus‐Eluting Stent Versus Durable‐Polymer Everolimus‐Eluting Stent for Percutaneous Coronary Revascularization: 2‐Year Results of the BIOSCIENCE Trial
por: Zbinden, Rainer, et al.
Publicado: (2016)

Open-labeled randomized controlled trial to evaluate the 1-year clinical outcomes of polymer-free sirolimus-eluting coronary stents as compared with biodegradable polymer-based sirolimus-eluting coronary stents
por: Viswanathan, Sunitha, et al.
Publicado: (2018)

Elastic stent recoil in coronary total occlusions: Comparison of durable‐polymer zotarolimus eluting stent and ultrathin strut bioabsorbable‐polymer sirolimus eluting stent
por: Improta, Riccardo, et al.
Publicado: (2021)

Polymer-free sirolimus-eluting stents in a large-scale all-comers population
por: Krackhardt, Florian, et al.
Publicado: (2017)

Clinical outcomes of ultrathin strut biodegradable polymer-coated everolimus-eluting stent in patients with coronary artery disease
por: Patted, Suresh V., et al.
Publicado: (2020)

High Bleeding Risk Patients Treated with Very Thin-Strut Biodegradable Polymer or Thin-Strut Durable Polymer Drug-Eluting Stents in the BIO-RESORT Trial
por: Zocca, Paolo, et al.
Publicado: (2018)

Outcome of percutaneous coronary intervention using ultrathin-strut biodegradable polymer sirolimus-eluting versus thin-strut durable polymer zotarolimus-eluting stents in patients with comorbid peripheral arterial disease: a post-hoc analysis from two randomized trials
por: Pinxterhuis, Tineke H., et al.
Publicado: (2023)

Arterial Healing 10 Months After Implantation of an Ultrathin-Strut, Biodegradable-Polymer, Sirolimus-Eluting Stent　― An Angioscopic Study ―
por: Tsujimura, Takuya, et al.
Publicado: (2021)

Safety and efficacy of biodegradable polymer-coated thin strut sirolimus-eluting stent vs. durable polymer-coated everolimus-eluting stent in patients with acute myocardial infarction
por: Gąsior, Paweł, et al.
Publicado: (2018)

Seven-year clinical outcomes in patients undergoing percutaneous coronary intervention with biodegradable polymer coated sirolimus-eluting stent: Results from a single-center real-world experience
por: Abhyankar, Atul, et al.
Publicado: (2018)

Real-World Clinical Outcomes of Indigenous Biodegradable Polymer Drug-Eluting Stents
por: Kumar, Basant, et al.
Publicado: (2021)

The Outcome of Ultrathin-Strut Biodegradable Polymer-Coated Sirolimus-Eluting Stents in Coronary Artery Disease Patients – A Feasibility Study
por: Panduranga, Prashanth, et al.
Publicado: (2023)

Thin Strut CoCr Biodegradable Polymer Biolimus A9-Eluting Stents versus Thicker Strut Stainless Steel Biodegradable Polymer Biolimus A9-Eluting Stents: Two-Year Clinical Outcomes
por: Menown, Ian B. A., et al.
Publicado: (2021)

Efficacy and Safety of Biodegradable Polymer Biolimus-Eluting Stents versus Durable Polymer Drug-Eluting Stents: A Meta-Analysis
por: Ye, Yicong, et al.
Publicado: (2013)

Clinical outcomes of biodegradable polymer biolimus-eluting BioMatrix stents versus durable polymer everolimus-eluting Xience stents
por: Lee, Da Hyon, et al.
Publicado: (2017)

Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes
por: Kakizaki, Ryota, et al.
Publicado: (2020)

Prospective evaluation of an ultrathin strut biodegradable polymer-coated sirolimus-eluting stent: 12 months’ results from the S-FLEX UK registry
por: Choudhury, Anirban, et al.
Publicado: (2019)

Comparison of the safety and efficacy of biodegradable polymer drug-eluting stents versus durable polymer drug-eluting stents: a meta-analysis
por: Lv, Jianfeng, et al.
Publicado: (2015)

Five‐Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus‐Eluting Stents Versus Durable Polymer Everolimus‐Eluting Stents
por: Iglesias, Juan F., et al.
Publicado: (2019)

Real-World Use Of Ultrathin-Strut Biodegradable Polymer–Coated Sirolimus-Eluting Stents In Patients With Coronary Artery Disease: 6-Month Clinical Outcomes
por: Ajmera, Prakash, et al.
Publicado: (2019)

Flexibility of Biodegradable Polymer Stents with Different Strut Geometries
por: Chen, Chong, et al.
Publicado: (2020)

Biological effect of microengineered grooved stents on strut healing: a randomised OCT-based comparative study in humans
por: Vesga, Boris, et al.
Publicado: (2017)

Multianalysis with optical coherence tomography and vasomotion in everolimus-eluting stents and everolimus-eluting biovascular scaffolds: the MOVES trial
por: Arroyo, Diego A, et al.
Publicado: (2018)

Assessment of anti-dislodgment capability for contemporary drug eluting stents
por: Ye, Yicong, et al.
Publicado: (2021)

Randomised comparison of drug-eluting versus bare-metal stenting in patients with non-ST elevation myocardial infarction
por: Remkes, Wouter S, et al.
Publicado: (2016)

“Burying” covered coronary stents under drug-eluting stents: A novel approach to ensure long-term stent patency
por: Bossard, Matthias, et al.
Publicado: (2023)

Ultrathin Struts Drug-Eluting Stents: A State-of-the-Art Review
por: Leone, Attilio, et al.
Publicado: (2022)

Is There an Advantage of Ultrathin-Strut Drug-Eluting Stents over Second- and Third-Generation Drug-Eluting Stents?
por: Gherasie, Flavius-Alexandru, et al.
Publicado: (2023)

Comparison of neointimal coverage between ultrathin biodegradable polymer‐coated sirolimus‐eluting stents and durable polymer‐coated everolimus‐eluting stents: 6 months optical coherence tomography follow‐up from the TAXCO study
por: Abhyankar, Atul, et al.
Publicado: (2020)

Biodegradable polymer drug-eluting stents versus first-generation durable polymer drug-eluting stents: A systematic review and meta-analysis of 12 randomized controlled trials
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2017)

Neointimal coverage of bare-metal and sirolimus-eluting stents evaluated with optical coherence tomography
por: Chen, B X, et al.
Publicado: (2008)

Randomised trial of the comparison of drug-eluting stents in patients with diabetes: OCT DES trial
por: Hamshere, Stephen, et al.
Publicado: (2018)

Comparison of short-term clinical outcomes between Resolute Onyx zotarolimus-eluting stents and everolimus-eluting stent in patients with acute myocardial infarction: Results from the Korea Acute Myocardial infarction Registry (KAMIR)
por: Kim, Yongcheol, et al.
Publicado: (2019)

Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis
por: Bangalore, Sripal, et al.
Publicado: (2013)

Biodegradable polymer versus second‐generation durable polymer drug‐eluting stents in patients with coronary artery disease: A meta‐analysis
por: Wu, James J., et al.
Publicado: (2018)

Recanalization of in-stent chronic total occlusion using intravascular lithotripsy and Firehawk(®) rapamycin target eluting coronary stents: A case report
por: Patrascu, Alexandru, et al.
Publicado: (2021)

Efficacy and safety of drug-eluting stents in elderly patients: A meta-analysis of randomized trials
por: Bae, SungA, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ph63ocnh9cpg39mn5i96euvr3m